Clinical Correlates and Outcomes of Dual Basiliximab and Antithymocyte Globulin Induction in Kidney Transplant Recipients: A National Study

Background. The unplanned use of dual induction therapy with interleukin-2 receptor-blocking antibodies (IL2rAb) and antithymocyte globulin (ATG) may portend adverse outcomes. Methods. We used national transplant registry data to study clinical correlates and outcomes of single versus dual induction...

Полное описание

Библиографические подробности

Главные авторы:	Ngan N. Lam, MD, Rachel Jeong, MD, Robert R. Quinn, MD, PhD, Pietro Ravani, MD, PhD, Huiling Xiao, MS, Mara McAdams-DeMarco, PhD, David A. Axelrod, MD, MBA, Mark A. Schnitzler, PhD, Jon J. Snyder, PhD, Krista L. Lentine, MD, PhD
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Wolters Kluwer 2021-08-01
Серии:	Transplantation Direct
Online-ссылка:	http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001190
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!